BTIG raised the firm’s price target on Castle Biosciences (CSTL) to $45 from $40 and keeps a Buy rating on the shares. The company ...
In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on COMPASS Pathways (CMPS – Research Report), with a ...
Tactile Systems (TCMD) stock was downgraded by BTIG to neutral as its Q3 revenue misses expectations. Read more here.